{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:05:11Z","timestamp":1761541511422,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.brachy.2019.02.003","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T09:01:17Z","timestamp":1558083677000},"page":"477-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Dose to the bladder neck in MRI-guided high-dose-rate prostate brachytherapy: Impact on acute urinary toxicity and health-related quality of life"],"prefix":"10.1016","volume":"18","author":[{"given":"Noelia","family":"Sanmamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Berlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna","family":"Adleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jette","family":"Borg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadeth","family":"Lao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeet","family":"Ghai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Weersink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Simeonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Rink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Menard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joelle","family":"Helou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2019.02.003_bib1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.radonc.2011.08.022","article-title":"Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?","volume":"100","author":"Morton","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.02.003_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2012.01.007","article-title":"Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer","volume":"103","author":"Hoskin","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.02.003_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2004.10.014","article-title":"Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer","volume":"74","author":"Astrom","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.02.003_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.brachy.2010.02.196","article-title":"Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT","volume":"9","author":"Deutsch","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.02.003_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brachy.2012.05.003","article-title":"Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer","volume":"12","author":"Kotecha","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.02.003_bib6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijrobp.2017.01.008","article-title":"ASCENDE-RT: an analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Rodda","year":"2017","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2019.02.003_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bju.12514","article-title":"Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer","volume":"114","author":"Spratt","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2019.02.003_bib8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ijrobp.2009.05.054","article-title":"Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life","volume":"77","author":"Morton","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.02.003_bib9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.radonc.2013.09.025","article-title":"High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: acute toxicity","volume":"110","author":"Hoskin","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.02.003_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.radonc.2007.10.030","article-title":"An analysis of the relation between physical characteristics of prostate I-125 seed implants and lower urinary tract symptoms: bladder hotspot dose and prostate size are significant predictors","volume":"88","author":"Steggerda","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.02.003_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ijrobp.2007.12.052","article-title":"Segmental urethral dosimetry and urinary toxicity in patients with no urinary symptoms before permanent prostate brachytherapy","volume":"72","author":"Thomas","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.02.003_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijrobp.2005.06.035","article-title":"The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy","volume":"64","author":"Niehaus","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.02.003_bib13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.radonc.2015.08.018","article-title":"Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: late toxicity and dose constraints","volume":"117","author":"Peters","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.02.003_bib14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clon.2017.01.042","article-title":"Long-term toxicity and health-related quality of life after single-fraction high dose rate brachytherapy boost and hypofractionated external beam radiotherapy for intermediate-risk prostate cancer","volume":"29","author":"Shahid","year":"2017","journal-title":"Clin Oncol"},{"key":"10.1016\/j.brachy.2019.02.003_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijrobp.2013.10.042","article-title":"Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer","volume":"88","author":"Ghadjar","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.02.003_bib16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijrobp.2014.06.031","article-title":"Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: implications for establishing new dose constraints for treatment planning","volume":"90","author":"Hathout","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.02.003_bib17","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1016\/j.brachy.2016.04.358","article-title":"Bladder neck variants: MRI versus ultrasound definition","volume":"15","author":"Dess","year":"2016","journal-title":"Brachytherapy"},{"first-page":"715","year":"2017","series-title":"Prostate. in: AJCC cancer staging manual","key":"10.1016\/j.brachy.2019.02.003_bib18"},{"key":"10.1016\/j.brachy.2019.02.003_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brachy.2015.12.004","article-title":"Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancer","volume":"15","author":"Murgic","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.02.003_bib20","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.ijrobp.2004.11.024","article-title":"Inverse treatment planning based on MRI for HDR prostate brachytherapy","volume":"61","author":"Citrin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.02.003_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.brachy.2016.12.013","article-title":"Prostate magnetic resonance imaging for brachytherapists: anatomy and technique","volume":"16","author":"Venkatesan","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.02.003_bib22","doi-asserted-by":"crossref","first-page":"20160348","DOI":"10.1259\/bjr.20160348","article-title":"Simple diagrammatic method to delineate male urethra in prostate cancer radiotherapy: an MRI based approach","volume":"89","author":"Kataria","year":"2016","journal-title":"Br J Radiol"},{"year":"2010","series-title":"Common terminology criteria for adverse events: CTCAE v4.0.","key":"10.1016\/j.brachy.2019.02.003_bib23"},{"key":"10.1016\/j.brachy.2019.02.003_bib24","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","article-title":"Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health- related quality of life in men with prostate cancer","volume":"56","author":"Wei","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2019.02.003_bib26","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"},{"key":"10.1016\/j.brachy.2019.02.003_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-56879-4_1","article-title":"Structure and function of the bladder neck","volume":"159","author":"Dorschner","year":"2001","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"10.1016\/j.brachy.2019.02.003_bib28","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jama.1953.02940320017005","article-title":"Anatomy and nerve supply of urinary bladder","volume":"153","author":"Van Duzen","year":"1953","journal-title":"JAMA"},{"key":"10.1016\/j.brachy.2019.02.003_bib29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.radonc.2008.09.013","article-title":"Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: comparison between loose and stranded seed implants","volume":"91","author":"Moerland","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.02.003_bib30","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.brachy.2017.05.009","article-title":"Focal brachytherapy for localized prostate cancer: urinary toxicity depends on tumor location","volume":"16","author":"Srougi","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.02.003_bib31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.radonc.2013.07.019","article-title":"Is there a relation between the radiation dose to the different sub-segments of the lower urinary tract and urinary morbidity after brachytherapy of the prostate with I-125 seeds?","volume":"109","author":"Steggerda","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.02.003_bib32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijrobp.2005.02.036","article-title":"Functional anatomy of the prostate: implications for treatment planning","volume":"63","author":"McLaughlin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.02.003_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijrobp.2010.01.022","article-title":"Acute urinary retention after I-125 prostate brachytherapy in relation to dose in different regions of the prostate","volume":"80","author":"Roeloffzen","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.02.003_bib34","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ijrobp.2010.06.017","article-title":"Predictors of urinary morbidity in Cs-131 prostate brachytherapy implants","volume":"81","author":"Smith","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118307426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118307426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:14:44Z","timestamp":1761531284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472118307426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1538472118307426"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2019.02.003","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose to the bladder neck in MRI-guided high-dose-rate prostate brachytherapy: Impact on acute urinary toxicity and health-related quality of life","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2019.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier Inc. on behalf of American Brachytherapy Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}